Abstract OC-142 Table 1

Hemospray monotherapyHemospray + additional endoscopic treatmentStandard endoscopic therapy + hemospray
Number of patients47827
Rockall score (median)676.5
Primary haemostasis46/47 (98%)6/8 (75%)19/27 (70%)
Rebleed (7 days)7/46 (15%)1/6 (17%)7/19 (37%)
Mortality (7 days)3/47 (6%)02/27 (7%)
Number of peptic ulcers19618
Proportion forrest 1a7/19 (37%)3/6 (50%)9/18 (50%)
Proportion forrest 1b10/19 (53%)3/6 (50%)8/18 (44%)
Unclassified2/1901/18